{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:36:59Z","timestamp":1773182219152,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T00:00:00Z","timestamp":1528243200000},"content-version":"vor","delay-in-days":370,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","onlinejacc.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jacc.2017.03.585","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T02:00:39Z","timestamp":1496196039000},"page":"2696-2706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011\u00a0to 2014"],"prefix":"10.1016","volume":"69","author":[{"given":"Robert S.","family":"Rosenson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Mefford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Bittner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keri L.","family":"Monda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuling","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Muntner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.03.585_bib1","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.03.585_bib2","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.03.585_bib3","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.03.585_bib4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jacc.2014.09.088","article-title":"Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease","volume":"65","author":"Rosenson","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.03.585_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jacc.2015.05.030","article-title":"Utilization of and adherence to guideline-recommended lipid-lowering therapy after acute coronary syndrome: opportunities for improvement","volume":"66","author":"Hirsh","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.03.585_bib6","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","volume":"58","author":"Smith","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.jacc.2017.03.585_bib7","doi-asserted-by":"crossref","first-page":"B10","DOI":"10.2337\/diacare.27.suppl_2.B10","article-title":"Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data","volume":"27","author":"Miller","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2017.03.585_bib8","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1111\/j.1475-6773.2004.00321.x","article-title":"Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions","volume":"39","author":"Rector","year":"2004","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jacc.2017.03.585_bib9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.mlr.0000160417.39497.a9","article-title":"Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors","volume":"43","author":"Birman-Deych","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.jacc.2017.03.585_bib10","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1161\/01.STR.0000032240.28636.BD","article-title":"Validating administrative data in stroke research","volume":"33","author":"Tirschwell","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2017.03.585_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/j.ajkd.2014.07.012","article-title":"Validation study of Medicare claims to identify older US adults with CKD using the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study","volume":"65","author":"Muntner","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2017.03.585_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archinternmed.2007.80","article-title":"Incidence and prevalence of heart failure in elderly persons 1994\u20132003","volume":"168","author":"Curtis","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2017.03.585_bib13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3233\/JAD-2009-1099","article-title":"The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited","volume":"17","author":"Taylor","year":"2009","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jacc.2017.03.585_bib14","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jamainternmed.2016.3384","article-title":"Effect of generic competition on atorvastatin prescribing and patients\u2019 out-of-pocket spending","volume":"176","author":"Luo","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2017.03.585_bib15","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(10)60310-8","article-title":"Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial","volume":"376","author":"Armitage","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.03.585_bib16","doi-asserted-by":"crossref","first-page":"2937678","DOI":"10.1155\/2016\/2937678","article-title":"Domperidone prescribing practices exposed patients to cardiac risk despite a \u201cblack box\u201d warning: a Canadian tertiary care center study","volume":"2016","author":"Forbes","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.jacc.2017.03.585_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/pds.2088","article-title":"Impact of implementing alerts about medication black-box warnings in electronic health records","volume":"20","author":"Yu","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2017.03.585_bib18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archinte.166.3.338","article-title":"Adherence to black box warnings for prescription medications in outpatients","volume":"166","author":"Lasser","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2017.03.585_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jamacardio.2016.5922","article-title":"Adoption of the 2013 American College of Cardiology\/American Heart Association cholesterol management guideline in cardiology practices nationwide","volume":"2","author":"Pokharel","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2017.03.585_bib20","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.03.585_bib21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-135-9-200111060-00012","article-title":"Clinical inertia","volume":"135","author":"Phillips","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2017.03.585_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/her\/18.2.156","article-title":"Understanding the potential of teachable moments: the case of smoking cessation","volume":"18","author":"McBride","year":"2003","journal-title":"Health Educ Res"},{"key":"10.1016\/j.jacc.2017.03.585_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1089\/jwh.2007.0443","article-title":"Gender differences in utilization of effective cardiovascular secondary prevention: a Cleveland Clinic prevention database study","volume":"17","author":"Cho","year":"2008","journal-title":"J\u00a0Womens Health"},{"key":"10.1016\/j.jacc.2017.03.585_bib24","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1161\/CIRCULATIONAHA.111.038265","article-title":"Statin use in outpatients with obstructive coronary artery disease","volume":"124","author":"Arnold","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.03.585_bib25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00005650-200503000-00011","article-title":"Quality improvement efforts and hospital performance: rates of beta-blocker prescription after acute myocardial infarction","volume":"43","author":"Bradley","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.jacc.2017.03.585_bib26","doi-asserted-by":"crossref","first-page":"e003576","DOI":"10.1161\/JAHA.116.003576","article-title":"Variation in practice regarding pretreatment with dual antiplatelet therapy for patients with non-ST elevation myocardial infarction","volume":"5","author":"Shafiq","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2017.03.585_bib27","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jacc.2016.12.036","article-title":"Statin intolerance and risk for recurrent myocardial infarction, coronary heart disease events and all-cause mortality following myocardial infarction","volume":"69","author":"Serban","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.03.585_bib28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/pds.3970","article-title":"Agreement between Medicare pharmacy claims, self-report, and medication inventory for assessing lipid-lowering medication use","volume":"25","author":"Colantonio","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2017.03.585_bib29","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/pds.3458","article-title":"Completeness of prescription information in US commercial claims databases","volume":"22","author":"Lauffenburger","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971736919X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971736919X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T09:08:12Z","timestamp":1535792892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510971736919X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":29,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S073510971736919X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.03.585","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011\u00a0to 2014","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.03.585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}